The Parkinson Study Group (PSG) is continually interested in expanding our clinical trial sites as opportunities for new Parkinson’s Disease studies become available. Regardless of location (hospital, community based, academic, or private practice), the PSG seeks trained Parkinson’s disease investigators who are committed to and experienced in clinical trials.

PSG Credentialing Program

The PSG welcomes the following newly credentialed investigators! 

Kathrin LaFaver, MD, University of Louisville, Louisville, KY
Michael Soileau, MD, Baylor Scott and White Hospital, Temple, TX
Pratap Chand, MD, St. Louis University, St. Louis, MO
Philippe Huot, MD, MSc, PhD, Univ of Montreal, Notre-Dame Hosp, Montreal, QC
Danish Bhatti, MD, University of Nebraska, Omaha, NE
Leslie Cloud, MD, Virginia Commonwealth, Richmond, VA
Taranum Khan, MD, Cleveland Clinic Florida, Weston, FL
Shyamal Mehta, MD, PhD, Mayo Clinic Arizona, Scottsdale, AZ

Current Standard Internal Credentialing Process

Please review the following materials before applying:

(Click on a link to download the relevant document).

Criteria to be eligible for credentialing:

PSG criteria for treating investigator

PSG criteria for non-treating investigator

PSG criteria for NP or PA investigator without prescriptive authority

Cover letter outline of application materials:

Letter for new treating investigator

Letter for new non-treating investigator

Letter for investigator moved to a new (NON-PSG) site

Yes, I'm interested in applying, Let's begin:

Application for treating investigator

Application for non-treating investigator

Application for Investigator moved to a new (NON-PSG) site

Other forms (if applicable):

Conflict-of-Interest Statement

Financial Agreement Form - non-profit sites

Financial Agreement Form - for-profit sites

To initiate the evaluation process by the PSG Credentials Committee, please submit your completed application electronically to Roseanna Battista.

Review Process and Timeline

The PSG Credentials Committee will review your application packet. They will base their decision on the following: Determination of approval or nonapproval (download). The Credentials Committee typically meets on a quarterly basis. If approved, you and your site will be added to our pool of potential participants and advised of upcoming PSG studies along with current PSG sites. The Steering Committee of each study makes the final decision on the selection of study investigators. Read more about the responsibilities of a credentialed investigator and review the PSG Constitution & ByLaws: Responsibilities of a credentialed investigator (download); PSG By-Laws (download); PSG Policies & Procedures (download).

PSG Credentialed Sites Map